Sierra MS, et al. Risk factors for non-human papillomavirus (HPV) Type 16/18 cervicalInfections and associated lesions among HPV DNA-negative women vaccinated against HPV-16/18 in the Costa Rica vaccine trial.
Bonde J, et al. Methylationmarkers FAM19A4 and miR124-2 as triage strategy for primary human papillomavirusscreen positive women: A large European multicenter study.
Koraka P, et al. Analysis of mouse brain transcriptome after experimental Duvenhage virus infection shows activation of innate immune response and pyroptotic cell death pathway.
Wahid R, et al. Genetic and phenotypic stability of poliovirus shed from infants who received novel type 2 or Sabin type 2 oral poliovirus vaccines in Panama: an analysis of two clinical trials.
Verhoef L, et al.Performance of DNA methylation analysis of ASCL1, LHX8, ST6GALNAC5, GHSR, ZIC1and SST for the triage of HPV-positive women: Results from a Dutch primary HPV-based screening cohort.
Pedersen H, et al. Clinical performance of the full genotyping agena massARRAY HPV assay using SurePath screening samples within the VALGENT4 Framework.